Scholarlink

Background <p><i>Orthohantaviruses</i> are zoonotic RNA viruses that cause hemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome. Their slow replication, lack of cytopathic effects, and variable biosafety requirements have long hindered the standardization of infection assays and antiviral testing. While serological and pseudotype-based systems enable high-throughput screening, scalable assays that directly quantify full-cycle <i>Orthohantavirus</i> infection remain limited.</p> Results <p>Here, we present a modular BSL-2 workflow that integrates standardized virus stock generation with complementary infection-quantification readouts. The platform combines (i) titration-guided pooling of daily supernatants to produce high-titer virus stocks without ultracentrifugation, (ii) a cross-reactive monoclonal antibody recognizing conserved nucleocapsid epitopes across multiple <i>Orthohantavirus</i> species, and (iii) three quantitative detection methods: qPCR, in-cell ELISA, and intracellular flow cytometry. Flow cytometry was used as the primary readout because it enables rapid, quantitative, single-cell detection of infection and can be readily integrated with multiparametric analyses. Using this system, we quantified the antiviral effects of rottlerin and observed distinct dose‒response profiles among Puumala, Tula, and Prospect Hill viruses.</p> Conclusion <p>Our workflow delivers a practical, reproducible, and scalable toolkit for comparative <i>Orthohantavirus</i> studies, enabling quantitative infection analysis and small-molecule testing under standard laboratory conditions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A Standardized workflow for Orthohantavirus production, detection, and antiviral screening

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月21日

查看全文
  • Hannah S. Schwarzer-Sperber,
  • Tamara Mussfeldt,
  • Julia Boesner,
  • Tina Dluzak,
  • Kathrin Sutter,
  • Roland Schwarzer

摘要

Background

Orthohantaviruses are zoonotic RNA viruses that cause hemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome. Their slow replication, lack of cytopathic effects, and variable biosafety requirements have long hindered the standardization of infection assays and antiviral testing. While serological and pseudotype-based systems enable high-throughput screening, scalable assays that directly quantify full-cycle Orthohantavirus infection remain limited.

Results

Here, we present a modular BSL-2 workflow that integrates standardized virus stock generation with complementary infection-quantification readouts. The platform combines (i) titration-guided pooling of daily supernatants to produce high-titer virus stocks without ultracentrifugation, (ii) a cross-reactive monoclonal antibody recognizing conserved nucleocapsid epitopes across multiple Orthohantavirus species, and (iii) three quantitative detection methods: qPCR, in-cell ELISA, and intracellular flow cytometry. Flow cytometry was used as the primary readout because it enables rapid, quantitative, single-cell detection of infection and can be readily integrated with multiparametric analyses. Using this system, we quantified the antiviral effects of rottlerin and observed distinct dose‒response profiles among Puumala, Tula, and Prospect Hill viruses.

Conclusion

Our workflow delivers a practical, reproducible, and scalable toolkit for comparative Orthohantavirus studies, enabling quantitative infection analysis and small-molecule testing under standard laboratory conditions.